Effect of fish oil supplement in maintenance hemodialysis patients: A systematic review and meta-analysis of published randomized controlled trials

European Journal of Clinical Pharmacology

Volumn 72, Issue 2, 2016, Pages 129-139

  He, Lei ^a   Li, Meng Si ^a   Lin, Mei ^a   Zhao, Tian Ya ^a   Gao, Ping ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Fish oil; Maintenance hemodialysis; Meta analysis; Randomized controlled trial

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; FISH OIL; HEMOGLOBIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; BECK DEPRESSION INVENTORY; CHOLESTEROL BLOOD LEVEL; COCHRANE LIBRARY; DIARRHEA; EMBASE; GASTROINTESTINAL SYMPTOM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; NAUSEA; PARATHYROID GLAND; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECONDARY HYPERPARATHYROIDISM; SYSTEMATIC REVIEW; VOMITING; WEB OF SCIENCE; DIETARY SUPPLEMENT;

DIETARY SUPPLEMENTS; FISH OILS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS;

EID: 84954220216     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-015-1976-y     Document Type: Review

References (41)

1. Kalender B, Ozdemir AC, Koroglu G (2006) Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin Pract 102:c115-c121
2. Friedman A, Moe S (2006) Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol 47:1064-1071
3. De Caterina R (2011) n-3 fatty acids in cardiovascular disease. N Engl J Med 364:2439-2450
4. Cohen SD, Norris L, Acquaviva K et al (2007) Screening, diagnosis, and treatment of depression in patients with end stage renal disease. Clin J Am Soc Nephrol 2:1332-1342
5. Vernaglione L, Cristofano C, Chimienti S (2008) Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study. J Nephrol 21:99-105
6. Rizos EC, Ntzani EE, Bika E et al (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 308(10):1024-1033
7. Kwak SM, Myung SK, Lee YJ et al (2012) Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 172(9):686-694
8. Rasic-Milutinovic Z, Perunicic G, Pljesa S et al (2007) Effects of n-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysispatients. Ren Fail 29:321-329
9. Bowden RG, Wilson RL, Deike E et al (2009) Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. Nutr Clin Pract 24:508-512
10. Tayyebi-Khosroshahi H, Houshyar J, Dehgan-Hesari R et al (2012) Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients. Saudi J Kidney Dis Transpl 23(3):500-506
11. Perunicic-Pekovic GB, Rasic ZR, Pljesa SI et al (2007) Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients. Nephrology (Carlton) 12:331-336
12. Noori N, Dukkipati R, Kovesdy CP et al (2011) Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. Am J Kidney Dis 58:248-256
13. Szklarek-Kubicka M, Fijałkowska-Morawska J, Zaremba-Drobnik D et al (2009) Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study. J Ren Nutr 19(6):487-493
14. Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12
15. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M et al (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609-613
16. Review Manager (RevMan) [Computer program] (2012) Version 5.2. Copenhagen: the Nordic Cochrane centre, the Cochrane collaboration
17. Svensson M, Schmidt EB, Jørgensen KA et al (2008) The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Nephrol Dial Transplant 23(9):2918-2924
18. Schmitz PG, McCloud LK, Reikes ST et al (2002) Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol 13(1):184-90
19. Tayebi-Khosroshahi H, Dehgan R, Habibi Asl B et al (2013) Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis patients. Iran J Kidney Dis 7(6):479-84
20. Saifullah A, Watkins BA, Saha C et al (2007) Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients-a pilot study. Nephrol Dial Transplant 22(12):3561-7
21. Svensson M, Schmidt EB, Jørgensen KA et al (2006) n-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol 1(4):780-786
22. Poulia KA, Panagiotakos DB, Tourlede E et al (2011) Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients. J Ren Nutr 21(6):479-484
23. Lok CE, Moist L, Hemmelgarn BR et al (2012) Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA 307(17):1809-16
24. Daud ZA, Tubie B, Adams J et al (2012) Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients. Vasc Health Risk Manag 8:187-195
25. Gharekhani A, Khatami MR, Dashti-Khavidaki S et al (2014) The effect of omega-3 fatty acids on depressive symptomsand inflammatorymarkers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial. Eur J Clin Pharmacol 70:655-666
26. Kooshki A, Taleban FA, Tabibi H et al (2011) Effects of marine omega-3 fatty acids on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients. Ann Nutr Metab 58(3):197-202
27. Hung AM, Booker C, Ellis CD et al (2015) Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients. Nephrol Dial Transplant 30(2):266-274
28. Bowden RG, Wilson RL, Gentile M et al (2007) Effects of omega-3 fatty acid supplementation on vascular access thrombosis in polytetrafluorethylene grafts. J Ren Nutr 17(2):126-131
29. Dashti-Khavidaki S, Gharekhani A, Khatami MR et al (2014) Effects of omega-3 fatty acids on depression and quality of life in maintenance hemodialysis patients. Am J Ther 21(4):275-287
30. Yevzlin AS, Chan MR, Becker YT et al (2010) "Venopathy" at work: recasting neointimal hyperplasia in a new light. Transl Res 156:216-25
31. He K, Song Y, Daviglus M et al (2004) Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109:2705-2711
32. Enns JE, Yeganeh A, Zarychanski R et al (2014) The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis. BMC Cardiovasc Disord 14:70
33. Taraz M, Khatami MR, Gharekhani A et al (2012) Relationship between a pro- and anti-inflammatory cytokine imbalance and depression in hemodialysis patients. Eur Cytokine Netw 23:179-186
34. Chilcot J, Wellsted D, Farrington K (2010) Depression in end-stage renal disease: current advances and research. Semin Dial 23:74-82
35. Vaváková M, ɰuračková Z, Trebatická J (2015) Markers of oxidative stress and neuroprogression in depression disorder. Oxid Med Cell Longev 2015:898393
36. Chalon S (2006) Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 75:259-269
37. 2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 58:591-620
38. Ewers B, Riserus U, Marckmann P (2009) Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients. J Ren Nutr 19(5):401-411
39. Gharekhani A, Khatami MR, Dashti-Khavidaki S et al (2014) Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients. J Ren Nutr 24(3):177-185
40. Young P, Lombi F, Finn BC et al (2011) "Malnutrition-inflammation complex syndrome" in chronic hemodialysis. Med B Aires 71(1):66-72
41. Gebauer SK, Psota TL, Harris WS et al (2006) n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83(Suppl 6):1526S-1535S